[go: up one dir, main page]

NO20020999D0 - Mesoprogestiner (progesteronreseptormodulatorer) for behandling og forhindring av godartete hormonavhengigegynekologiske sykdommer - Google Patents

Mesoprogestiner (progesteronreseptormodulatorer) for behandling og forhindring av godartete hormonavhengigegynekologiske sykdommer

Info

Publication number
NO20020999D0
NO20020999D0 NO20020999A NO20020999A NO20020999D0 NO 20020999 D0 NO20020999 D0 NO 20020999D0 NO 20020999 A NO20020999 A NO 20020999A NO 20020999 A NO20020999 A NO 20020999A NO 20020999 D0 NO20020999 D0 NO 20020999D0
Authority
NO
Norway
Prior art keywords
mesoprogestins
prevention
treatment
receptor modulators
progesterone receptor
Prior art date
Application number
NO20020999A
Other languages
English (en)
Other versions
NO20020999L (no
Inventor
Kristof Chwalisz
Walter Elger
Gerd Schubert
Original Assignee
Jenapharm Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jenapharm Gmbh filed Critical Jenapharm Gmbh
Publication of NO20020999D0 publication Critical patent/NO20020999D0/no
Publication of NO20020999L publication Critical patent/NO20020999L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/04—Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32—Antioestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34—Gestagens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pyridine Compounds (AREA)
NO20020999A 1999-08-31 2002-02-28 Mesoprogestiner (progesteronreseptormodulatorer) for behandling og forhindring av godartete hormonavhengigegynekologiske sykdommer NO20020999L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US38614199A 1999-08-31 1999-08-31
PCT/US2000/023770 WO2001015679A2 (en) 1999-08-31 2000-08-31 Mesoprogestins for the treatment and prevention of benign hormone dependent gynecological disorders

Publications (2)

Publication Number Publication Date
NO20020999D0 true NO20020999D0 (no) 2002-02-28
NO20020999L NO20020999L (no) 2002-03-14

Family

ID=23524338

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20020999A NO20020999L (no) 1999-08-31 2002-02-28 Mesoprogestiner (progesteronreseptormodulatorer) for behandling og forhindring av godartete hormonavhengigegynekologiske sykdommer

Country Status (34)

Country Link
EP (1) EP1229906B1 (no)
JP (1) JP2003535029A (no)
KR (3) KR20080066095A (no)
AR (1) AR025457A1 (no)
AT (1) ATE375160T1 (no)
AU (1) AU781840B2 (no)
BG (1) BG65817B1 (no)
BR (1) BR0014161A (no)
CA (1) CA2382580C (no)
CO (1) CO5200772A1 (no)
CZ (1) CZ2002704A3 (no)
DE (1) DE60036723T2 (no)
DK (1) DK1229906T3 (no)
EA (1) EA007854B1 (no)
EE (1) EE05172B1 (no)
ES (1) ES2295050T3 (no)
HR (1) HRP20020267A2 (no)
HU (1) HUP0202429A3 (no)
IL (1) IL148416A0 (no)
LT (1) LT5034B (no)
LV (1) LV12941B (no)
ME (1) MEP13808A (no)
MX (1) MXPA02002191A (no)
NO (1) NO20020999L (no)
NZ (1) NZ517471A (no)
PE (1) PE20010578A1 (no)
PL (1) PL198790B1 (no)
PT (1) PT1229906E (no)
RO (1) RO122179B1 (no)
RS (1) RS50283B (no)
SI (1) SI20852B (no)
SK (1) SK287192B6 (no)
UA (1) UA78184C2 (no)
WO (1) WO2001015679A2 (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10236405A1 (de) 2002-08-02 2004-02-19 Schering Ag Progesteronrezeptormodulatoren mit erhöhter antigonadotroper Aktivität für die weibliche Fertilitätskontrolle und Hormonersatztherapie
AU2003255355A1 (en) * 2002-08-02 2004-02-25 Schering Aktiengesellschaft Progesterone receptor modulators having an increased antigonadotropic activity for use in female fertility testing and hormone replacement therapy
US20040097591A1 (en) * 2002-11-18 2004-05-20 Kristof Chwalisz Use of selective progesterone receptor modulators for the treatment of androgen deficiency
DE102007011105A1 (de) 2007-03-02 2008-09-04 Bayer Schering Pharma Aktiengesellschaft Mineralcorticoid-Rezeptor-Antagonisten zur Behandlung von Endometriose
CN106890168A (zh) * 2009-06-17 2017-06-27 国立大学法人熊本大学 痛经的预防和/或治疗药
US8399432B2 (en) * 2009-10-27 2013-03-19 Lipogen Ltd. Compositions and methods of treatment for alleviating premenstrual syndrome symptoms
JP2022548314A (ja) * 2019-09-23 2022-11-17 ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー 妊娠を遷延させるためおよび月経または妊娠の合併症の処置の方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3633244A1 (de) 1986-09-26 1988-03-31 Schering Ag Antigestagene zur hemmung der uterinen prostaglandinsynthese
DE4332284C2 (de) 1993-09-20 1997-05-28 Jenapharm Gmbh 11-Benzaldoxim-17beta-methoxy-17alpha-methoxymethyl-estradien-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE4332283A1 (de) * 1993-09-20 1995-04-13 Jenapharm Gmbh Neue 11-Benzaldoximestradien-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
US5681817A (en) * 1994-02-04 1997-10-28 The Medical College Of Hampton Roads Treatment of ovarian estrogen dependent conditions
US5576310A (en) * 1994-09-20 1996-11-19 Jenapharm Gmbh 11-benzaldoxime-17β-methoxy-17α-methoxymethyl-estrasdiene derivatives, methods for their production and pharmaceuticals containing such compounds
WO1996019458A2 (en) * 1994-12-22 1996-06-27 Ligand Pharmaceuticals Incorporated Steroid receptor modulator compounds and methods
US5693647A (en) * 1994-12-22 1997-12-02 Ligand Pharmaceuticals Incorporated Steroid receptor modulator compounds and methods
KR100370908B1 (ko) 1995-02-02 2003-04-10 쉐링 악티엔게젤샤프트 기능부전성자궁출혈치료용약제의제조에유용한프로게스테론길항제
DE19604231A1 (de) * 1996-01-29 1997-07-31 Schering Ag Pharmazeutisches Kombinationspräparat und seine Verwendung zur Behandlung von gynäkologischen Störungen
EP0900234B1 (en) * 1996-05-01 2000-07-05 THE GOVERNMENT OF THE UNITED STATES OF AMERICA as represented by the SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES 21-substituted progesterone derivatives as new antiprogestational agents
WO1998005679A2 (en) * 1996-08-05 1998-02-12 Duke University Mixed agonists of the progesterone receptor and assays therefor
DE19809845A1 (de) * 1998-03-03 1999-09-09 Jenapharm Gmbh S-substituierte 11beta-Benzaldoxim-estra-4,9-dien-kohlensäurethiolester, Verfahren zu deren Herstellung und diese Verbindungen enthaltende pharmazeutische Zubereitungen
WO2000042031A2 (en) * 1999-01-14 2000-07-20 Bayer Corporation Substituted 2-arylimino heterocycles and compositions containing them, for use as progesterone receptor binding agents
EP1175422A2 (en) * 1999-05-04 2002-01-30 Ligand Pharmaceuticals Incorporated Tetracyclic progesterone receptor modulator compounds and methods

Also Published As

Publication number Publication date
YU14002A (sh) 2006-01-16
BG65817B1 (bg) 2010-01-29
CA2382580C (en) 2009-05-19
HUP0202429A3 (en) 2004-04-28
DE60036723T2 (de) 2008-07-17
CA2382580A1 (en) 2001-03-08
ATE375160T1 (de) 2007-10-15
JP2003535029A (ja) 2003-11-25
AR025457A1 (es) 2002-11-27
NO20020999L (no) 2002-03-14
KR100864547B1 (ko) 2008-10-20
DK1229906T3 (da) 2008-02-11
NZ517471A (en) 2004-02-27
PT1229906E (pt) 2008-01-18
CO5200772A1 (es) 2002-09-27
PL198790B1 (pl) 2008-07-31
MXPA02002191A (es) 2002-09-30
SK287192B6 (sk) 2010-02-08
KR20070058023A (ko) 2007-06-07
RS50283B (sr) 2009-09-08
RO122179B1 (ro) 2009-02-27
HRP20020267A2 (en) 2004-04-30
EA200200282A1 (ru) 2002-10-31
LT5034B (lt) 2003-07-25
BG106442A (bg) 2002-09-30
EP1229906B1 (en) 2007-10-10
KR100755109B1 (ko) 2007-09-04
PL353930A1 (en) 2003-12-15
AU6946600A (en) 2001-03-26
WO2001015679A2 (en) 2001-03-08
PE20010578A1 (es) 2001-06-04
WO2001015679A3 (en) 2001-11-22
KR20020027616A (ko) 2002-04-13
ES2295050T3 (es) 2008-04-16
KR20080066095A (ko) 2008-07-15
IL148416A0 (en) 2002-09-12
SI20852A (sl) 2002-10-31
CZ2002704A3 (cs) 2003-02-12
LT2002031A (en) 2003-02-25
EE05172B1 (et) 2009-06-15
SK2992002A3 (en) 2002-07-02
EP1229906A2 (en) 2002-08-14
UA78184C2 (en) 2007-03-15
EA007854B1 (ru) 2007-02-27
HUP0202429A2 (en) 2002-10-28
LV12941B (en) 2003-06-20
AU781840B2 (en) 2005-06-16
SI20852B (sl) 2009-06-30
EE200200104A (et) 2003-04-15
BR0014161A (pt) 2002-05-21
DE60036723D1 (de) 2007-11-22
MEP13808A (en) 2010-06-10

Similar Documents

Publication Publication Date Title
NO20020912D0 (no) Bicykliske androgen- og progesteronreseptorer- modulatorforbindelser og fremgangsmåter
NO20014379D0 (no) Anvendelse av Xenon for behandling av Neurointoksikasjoner
DE60023982D1 (de) System zur Behandlung von benigner Prostatahyperplasie
NO20013380D0 (no) 2-aminobenzoksazinonderivater for behandling av fedme
ATE293971T1 (de) Pharmazeutische kombinationen enthaltend tegaserod und omeprazole und ihre verwendung zur behandlung gastrointestinaler krankheiten
NO20024478D0 (no) Hormonerstatningsterapi ved anvendelse av kombinasjon av konjugerte östrogener og medroksyprogesteronacetat
NO20022925L (no) EP4 reseptor selektive agonister for behandling av osteoporose
ATE293447T1 (de) 2-oxy-benzoxazinonderivate zur behandlung von fettleibigkeit
ATE269303T1 (de) Arylpiperazinyl-cyclohexyl indolderivate zur behandlung von depressionen
HUP0202049A3 (en) Indole derivatives and their use for the treatment of osteoporosis amongst other applications
NO20015542D0 (no) Fremgangsmåte for fremstilling og anvendelse av N- desmetylzopikloner
NO20005885D0 (no) Kombinasjonsterapi for behandling av refraktær depresjon
NO20020999D0 (no) Mesoprogestiner (progesteronreseptormodulatorer) for behandling og forhindring av godartete hormonavhengigegynekologiske sykdommer
NO20011537D0 (no) Kjemokinreseptorpeptidvaksiner for behandling og forebygging av diabetes
NO20003229D0 (no) Kombinasjon av benzosykloheptapyridinforbindelser og antineoplastiske legemidler for behandling av proliferaktive sykdommer
NO983512D0 (no) Midler for behandling og forhindring av AIDS
NO20014049D0 (no) Kontrollert frigjorings-formulering for behandling av COPD
DK1239862T3 (da) Farmaceutisk præparat indeholdende cytostatika og eletronacceptorer til behandling af kræft
AU3270301A (en) Combined pde3 and pde4 inhibitor therapy for the treatment of obesity
NO20013651D0 (no) Anvendelse av fosfororganiske forbindelser for profylaktisk og terapeutisk behandling av infeksjoner
NO20023841D0 (no) Anvendelse av glukokortikoidreseptorantagonister for forebygging og behandling av sykdommer av reproduksjonssystemethos menn
NO20022142L (no) Anvendelse av dopamin-D3 reseptor agonister for behandling av saltavhengig hypertensjon
GB9926985D0 (en) Use of substituted (quinolin-2-yl-methoxy)phenyl-acyl-sulphonamides and-cyanamides for the treatment of diseases
HK1043991A1 (zh) 作為黃體酮受體調節劑的喹唑啉酮及苯並噁嗪衍生物
SI1212317T1 (en) Indole derivatives and their use for the treatment of osteoporosis amongst other applications

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application
FC2A Withdrawal, rejection or dismissal of laid open patent application